Compugen Ltd.
CGEN
$2.11
-$0.05-2.32%
Weiss Ratings | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | D+ | |||
Rating Factors | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.96 | |||
Price History | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -1.05% | |||
30-Day Total Return | -29.85% | |||
60-Day Total Return | -21.99% | |||
90-Day Total Return | 148.87% | |||
Year to Date Total Return | -5.76% | |||
1-Year Total Return | 218.64% | |||
2-Year Total Return | -18.61% | |||
3-Year Total Return | -78.83% | |||
5-Year Total Return | -46.44% | |||
52-Week High % Change | -37.30% | |||
52-Week Low % Change | 258.49% | |||
Price | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $3.03 | |||
52-Week Low Price | $0.53 | |||
52-Week Low Price (Date) | Nov 13, 2023 | |||
52-Week High Price (Date) | Mar 08, 2024 | |||
Valuation | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 170.11M | |||
Enterprise Value | 120.77M | |||
Price/Earnings (TTM) | 542.86 | |||
Earnings Per Share (TTM) | 0.00 | |||
Earnings Per Share Growth | -100.90% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 5.02 | |||
Price/Book (Q) | 2.59 | |||
Enterprise Value/Revenue (TTM) | 3.61 | |||
Price | $1.88 | |||
Enterprise Value/EBITDA (TTM) | 15.08 | |||
Enterprise Value/EBIT | 15.54 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 88.42M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 972 3 765 8585 | |||
Address | -- | |||
Website | cgen.com | |||
Country | Israel | |||
Year Founded | 1993 | |||
Profitability | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | $0.38 | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | 346.12% | |||
Earnings Growth (Q YOY) | 414.13% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | 401.92% | |||
Balance Sheet | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 50.69M | |||
Cash Per Share (Q) | $0.57 | |||
Total Current Assets (Q) | 114.58M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 65.56M | |||
Current Ratio (Q) | 4.362 | |||
Book Value Per Share (Q) | $0.73 | |||
Total Assets (Q) | 121.33M | |||
Total Current Liabilities (Q) | 26.27M | |||
Total Debt (Q) | 1.35M | |||
Total Liabilities (Q) | 55.78M | |||
Total Common Equity (Q) | 65.56M | |||
Cash Flow | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||